Yahoo
ASX - Delayed Quote AUD

Clarity Pharmaceuticals Ltd (CU6.AX)

1.5700 -0.1000 (-5.99%)
At close: October 30 at 4:10:11 PM GMT+11
View in AlphaSpace Currency in AUD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
6/30/2026
6/30/2025
6/30/2024
6/30/2023
Operating Expense
118,906.6750
118,906.6750
78,556.8530
56,307.3220
36,164.0620
Operating Income
-118,906.6750
-118,906.6750
-78,556.8530
-56,307.3220
-36,164.0620
Net Non Operating Interest Income Expense
8,003.6860
8,003.6860
4,762.4300
2,771.3800
1,864.2600
Other Income Expense
4,620.2450
4,620.2450
9,915.4940
11,506.6650
9,800.5560
Pretax Income
-106,282.7440
-106,282.7440
-63,878.9290
-42,029.2770
-24,499.2460
Tax Provision
860.5590
860.5590
416.5060
295.1510
103.2000
Net Income Common Stockholders
-107,241.8280
-107,241.8280
-64,295.4350
-42,324.4280
-24,602.4460
Basic EPS
-0.29
-0.29
-0.20
-0.15
-0.09
Diluted EPS
-0.29
-0.29
-0.20
-0.15
-0.09
Basic Average Shares
368,025.8680
368,025.8680
319,198.1140
273,158.1890
260,410.3370
Diluted Average Shares
368,025.8680
368,025.8680
319,198.1140
273,158.1890
260,410.3370
Net Income from Continuing & Discontinued Operation
-107,241.8280
-107,241.8280
-64,295.4350
-42,324.4280
-24,602.4460
Normalized Income
-107,143.3030
-107,143.3030
-64,295.4350
-42,324.4280
-24,602.4460
Interest Income
8,003.6860
8,003.6860
4,762.4300
2,771.3800
1,864.2600
Net Interest Income
8,003.6860
8,003.6860
4,762.4300
2,771.3800
1,864.2600
EBIT
-118,906.6750
-118,906.6750
-78,556.8530
-56,307.3220
-36,164.0620
EBITDA
-118,623.1450
-118,623.1450
-78,371.7700
-56,154.2540
-36,063.5490
Reconciled Depreciation
283.5300
283.5300
185.0830
153.0680
100.5130
Net Income from Continuing Operation Net Minority Interest
-107,143.3030
-107,143.3030
-64,295.4350
-42,324.4280
-24,602.4460
Normalized EBITDA
-118,623.1450
-118,623.1450
-78,371.7700
-56,154.2540
-36,063.5490
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2023 - 8/25/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: